ClinicalTrials.gov
public full text
Public Domain
Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
The study will evaluate the safety and efficacy of melatonin supplementation in CKD and ESRD patients with sleep disorders to reduce sleep latency times, the number of apnea/hypopneic episodes, and prolong duration in rapid eye movement (REM) sleep in CKD and ESRD patients with sleep disordered breathing.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema#889814
- French Validation of a Severity Scale in REM Sleep Behavior Disorder (SEV-TCSP)#1138399
- Development and evaluation of the Sleep Treatment and Education Program for Students (STEPS)#958245
- The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation#806882
- Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness#841040
Record · ID 869426
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive